[1]李朕,李琦,杨军用,等.十三味健胃饮与胃复春片治疗胃癌前病变疗效比较[J].西部中医药,2019,32(05):81-83.
　LI Zhen,LI Qi,YANG Junyong,et al.The Comparison of Clinical Effects of ShiSanWei JianWei Drink and WeiFuChun Tablets in the Treatment for Precancerous Lesion of Gastric Cancer[J].Western Journal of Traditional Chinese Medicine,2019,32(05):81-83.
点击复制

十三味健胃饮与胃复春片治疗胃癌前病变疗效比较
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
32
期数:
2019年05期
页码:
81-83
栏目:
出版日期:
2019-05-15

文章信息/Info

Title:
The Comparison of Clinical Effects of ShiSanWei JianWei Drink and WeiFuChun Tablets in the Treatment for Precancerous Lesion of Gastric Cancer
文章编号:
1004-6852(2019)05-0081-03
作者:
李朕，李琦，杨军用，周云，林红，蒲雪燕，袁今奇，杨百京△
石河子大学医学院第一附属医院，新疆 石河子 832000
Author(s):
LI Zhen, LI Qi, YANG Junyong, ZHOU Yun, LIN Hong, PU Xueyan, YUAN Jinqi, YANG Baijing△
The First Affiliated Hospital of the Medical College, Shihezi University, Shihezi 832000, China
关键词:
胃癌前病变; 十三味健胃饮; 胃复春片
Keywords:
precancerous lesion of gastric cancer;  ShiSanWei JianWei drink;  WeiFuChun tablets
分类号:
R286
摘要:
目的：比较十三味健胃饮与胃复春片治疗胃癌前病变的临床疗效。方法：将胃癌前病变患者60例按就诊时间先后随机分为观察组、对照组各30例。对照组口服胃复春片，观察组口服十三味健胃饮，对比2组临床疗效与病理结果。结果：总有效率观察组为90.0%，高于对照组的70.0%，2组比较差异有统计学意义(P＜0.05)，干预后观察组中医症状评分降低，低于干预前及干预后对照组评分，差异有统计学意义(P＜0.05)；临床病理疗效比较，总有效率观察组为90.0%，高于对照组的70.0%，与临床有效率具有一致性，2组比较差异有统计学意义(P＜0.05)。结论：十三味健胃饮治疗胃癌前病变临床效果优于胃复春片。
Abstract:
Objective: To compare clinical effects of ShiSanWei JianWei drink and WeiFuChun tablets in the treatment for precancerous lesion of gastric cancer. Methods: Sixty patients were allocated to the observation group and the control group according to visiting time, 30 cases each group. The control group took WeiFuChun tablets, and the observation group ShiSanWei JianWei drink, to compare clinical effects and pathological effects between both groups. Results: Total effective rate of the observation group was 90.0%, higher than 70.0% of the control group, and the difference showed statistical meaning (P＜0.05), after the intervention, TCM symptom scores of the observation group decreased, which were lower than before the intervention and the scores of the control group after the intervention, and the difference was statistically significant (P＜0.05); the comparison of clinical effects of pathology, total effective rate of the observation group was 90.0%, higher than 70.0% of the control group, it possessed the uniformity with clinical effective rate, and the difference had statistical meaning (P＜0.05). Conclusion: ShiSanWei JianWei drink is superior to WeiFuChun tablets in the treatment for precancerous lesion of gastric cancer.

相似文献/References:

[1]董刘佳,苗嘉萌,袁红霞.袁红霞教授从疏利三焦探讨胃癌前病变辨治思路[J].西部中医药,2021,34(07):58.[doi:10.12174/j.issn.2096-9600.2021.07.14]
　DONG Liujia,MIAO Jiameng,YUAN Hongxia.Professor Yuan Hongxia’s Thinking on Differentiating and Treating Precancerous Lesions of Gastric Cancer from Dredging Triple Energizer[J].Western Journal of Traditional Chinese Medicine,2021,34(05):58.[doi:10.12174/j.issn.2096-9600.2021.07.14]
[2]李盟,赵迪,杜燕青,等.参佛胃康治疗慢性萎缩性胃炎胃癌前病变作用机制研究[J].西部中医药,2024,37(09):30.[doi:10.12174/j.issn.2096-9600.2024.09.07]
　LI Meng,ZHAO Di,DU Yanqing,et al.Study on the Mechansim of Shenfo Weikang in the Treatment of Precancerous Lesions of Gastric Cancer: Chronic Atrophic Gastritis[J].Western Journal of Traditional Chinese Medicine,2024,37(05):30.[doi:10.12174/j.issn.2096-9600.2024.09.07]

备注/Memo

备注/Memo:
收稿日期：2018-10-11 *基金项目：兵团科技公关与成果转化计划项目(编号 2015AD010)；国家中医药管理局全国名老中医药专家传承工作室建设项目（编号国中医药人教发[2014]20号）。 作者简介：李朕(1986—)，女，硕士学位，主治医师。研究方向：脾胃病的中西医结合诊治。 △通讯作者：杨百京(1964—)，男，主任医师，教授。研究方向：脾胃病的中西医结合治疗。
更新日期/Last Update: 2019-05-15